US Stock MarketDetailed Quotes

VIRX Viracta Therapeutics

Watchlist
  • 0.580
  • -0.138-19.22%
Close Jun 4 16:00 ET
  • 0.600
  • +0.020+3.45%
Post 18:52 ET
22.78MMarket Cap-471P/E (TTM)

Viracta Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
13.67%13.88M
0.21%50.69M
17.17%13.56M
-30.99%12.48M
18.51%12.45M
17.01%12.21M
96.10%50.59M
2.26%11.57M
67.40%18.08M
12.75%10.51M
Selling and administrative expenses
-14.78%3.92M
-28.79%17.32M
-14.72%4.15M
-60.54%4.32M
1.72%4.25M
6.09%4.6M
57.59%24.33M
21.32%4.87M
194.77%10.94M
8.01%4.18M
-General and administrative expense
-14.78%3.92M
-28.79%17.32M
-14.72%4.15M
-60.54%4.32M
1.72%4.25M
6.09%4.6M
57.59%24.33M
21.32%4.87M
194.77%10.94M
8.01%4.18M
Research and development costs
30.88%9.96M
27.06%33.37M
40.34%9.41M
14.27%8.16M
29.62%8.2M
24.79%7.61M
10.06%26.26M
-8.22%6.7M
0.72%7.14M
16.12%6.32M
Operating profit
-13.67%-13.88M
-0.21%-50.69M
-17.17%-13.56M
30.99%-12.48M
-18.51%-12.45M
-17.01%-12.21M
-96.10%-50.59M
-2.26%-11.57M
-67.40%-18.08M
-12.75%-10.51M
Net non-operating interest income expense
-13,200.00%-266K
-160.44%-359K
-143.78%-197K
-137.61%-126K
55.84%-34K
98.25%-2K
231.13%594K
448.84%450K
391.30%335K
30.00%-77K
Non-operating interest income
-32.57%592K
185.65%3.35M
18.05%752K
74.47%827K
1,674.00%887K
8,680.00%878K
2,981.58%1.17M
6,270.00%637K
4,640.00%474K
316.67%50K
Non-operating interest expense
-2.50%858K
541.94%3.7M
407.49%949K
585.61%953K
625.20%921K
609.68%880K
17.52%577K
34.53%187K
11.20%139K
4.10%127K
Other net income (expense)
5M
-100.75%-6K
-7K
1K
100.90%798K
Gain on sale of security
--1K
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
--5M
-100.75%-6K
---7K
--1K
----
----
375.17%798K
----
----
----
Income before tax
25.13%-9.14M
-3.78%-51.06M
-33.30%-13.77M
28.99%-12.6M
-17.97%-12.48M
-15.77%-12.21M
57.13%-49.2M
9.79%-10.33M
-18.97%-17.74M
-15.40%-10.58M
Income tax
Net income
25.13%-9.14M
-3.78%-51.06M
-33.30%-13.77M
28.99%-12.6M
-17.97%-12.48M
-15.77%-12.21M
57.13%-49.2M
9.79%-10.33M
-18.97%-17.74M
-15.40%-10.58M
Net income continuous Operations
25.13%-9.14M
-3.78%-51.06M
-33.30%-13.77M
28.99%-12.6M
-17.97%-12.48M
-15.77%-12.21M
57.13%-49.2M
9.79%-10.33M
-18.97%-17.74M
-15.40%-10.58M
Minority interest income
Net income attributable to the parent company
25.13%-9.14M
-3.78%-51.06M
-33.30%-13.77M
28.99%-12.6M
-17.97%-12.48M
-15.77%-12.21M
57.13%-49.2M
9.79%-10.33M
-18.97%-17.74M
-15.40%-10.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
25.13%-9.14M
-3.78%-51.06M
-33.30%-13.77M
28.99%-12.6M
-17.97%-12.48M
-15.77%-12.21M
57.13%-49.2M
9.79%-10.33M
-18.97%-17.74M
-15.40%-10.58M
Basic earnings per share
28.13%-0.23
-1.54%-1.32
-29.63%-0.35
29.79%-0.33
-14.29%-0.32
-14.29%-0.32
63.89%-1.3
12.90%-0.27
-17.50%-0.47
-12.00%-0.28
Diluted earnings per share
28.13%-0.23
-1.54%-1.32
-29.63%-0.35
29.79%-0.33
-14.29%-0.32
-14.29%-0.32
63.89%-1.3
12.90%-0.27
-17.50%-0.47
-12.00%-0.28
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 13.67%13.88M0.21%50.69M17.17%13.56M-30.99%12.48M18.51%12.45M17.01%12.21M96.10%50.59M2.26%11.57M67.40%18.08M12.75%10.51M
Selling and administrative expenses -14.78%3.92M-28.79%17.32M-14.72%4.15M-60.54%4.32M1.72%4.25M6.09%4.6M57.59%24.33M21.32%4.87M194.77%10.94M8.01%4.18M
-General and administrative expense -14.78%3.92M-28.79%17.32M-14.72%4.15M-60.54%4.32M1.72%4.25M6.09%4.6M57.59%24.33M21.32%4.87M194.77%10.94M8.01%4.18M
Research and development costs 30.88%9.96M27.06%33.37M40.34%9.41M14.27%8.16M29.62%8.2M24.79%7.61M10.06%26.26M-8.22%6.7M0.72%7.14M16.12%6.32M
Operating profit -13.67%-13.88M-0.21%-50.69M-17.17%-13.56M30.99%-12.48M-18.51%-12.45M-17.01%-12.21M-96.10%-50.59M-2.26%-11.57M-67.40%-18.08M-12.75%-10.51M
Net non-operating interest income expense -13,200.00%-266K-160.44%-359K-143.78%-197K-137.61%-126K55.84%-34K98.25%-2K231.13%594K448.84%450K391.30%335K30.00%-77K
Non-operating interest income -32.57%592K185.65%3.35M18.05%752K74.47%827K1,674.00%887K8,680.00%878K2,981.58%1.17M6,270.00%637K4,640.00%474K316.67%50K
Non-operating interest expense -2.50%858K541.94%3.7M407.49%949K585.61%953K625.20%921K609.68%880K17.52%577K34.53%187K11.20%139K4.10%127K
Other net income (expense) 5M-100.75%-6K-7K1K100.90%798K
Gain on sale of security --1K------------------------------------
Other non- operating income (expenses) --5M-100.75%-6K---7K--1K--------375.17%798K------------
Income before tax 25.13%-9.14M-3.78%-51.06M-33.30%-13.77M28.99%-12.6M-17.97%-12.48M-15.77%-12.21M57.13%-49.2M9.79%-10.33M-18.97%-17.74M-15.40%-10.58M
Income tax
Net income 25.13%-9.14M-3.78%-51.06M-33.30%-13.77M28.99%-12.6M-17.97%-12.48M-15.77%-12.21M57.13%-49.2M9.79%-10.33M-18.97%-17.74M-15.40%-10.58M
Net income continuous Operations 25.13%-9.14M-3.78%-51.06M-33.30%-13.77M28.99%-12.6M-17.97%-12.48M-15.77%-12.21M57.13%-49.2M9.79%-10.33M-18.97%-17.74M-15.40%-10.58M
Minority interest income
Net income attributable to the parent company 25.13%-9.14M-3.78%-51.06M-33.30%-13.77M28.99%-12.6M-17.97%-12.48M-15.77%-12.21M57.13%-49.2M9.79%-10.33M-18.97%-17.74M-15.40%-10.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 25.13%-9.14M-3.78%-51.06M-33.30%-13.77M28.99%-12.6M-17.97%-12.48M-15.77%-12.21M57.13%-49.2M9.79%-10.33M-18.97%-17.74M-15.40%-10.58M
Basic earnings per share 28.13%-0.23-1.54%-1.32-29.63%-0.3529.79%-0.33-14.29%-0.32-14.29%-0.3263.89%-1.312.90%-0.27-17.50%-0.47-12.00%-0.28
Diluted earnings per share 28.13%-0.23-1.54%-1.32-29.63%-0.3529.79%-0.33-14.29%-0.32-14.29%-0.3263.89%-1.312.90%-0.27-17.50%-0.47-12.00%-0.28
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg